EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial ...

Health Canada has granted a notice of compliance for Novartis Canada’s Kisqali (ribociclib tablets) plus an aromatase ...

As Dr. Geary transitions out of his role, he will continue as a strategic consultant through 2026 to ensure continuity. Ionis ...

During a live event, Neal E. Ready, MD, and participants discussed use of PD-L1 status in non–small cell lung cancer and ...

The CAR-T Cell Therapy Market is growing rapidly with expanding indications, rising trials, and innovations in solid tumor and autoimmune applications.

Modus, a trusted partner for leading brands like Novartis and Moody's, pairs AI with senior practitioners to drive businesses forward. NEW YORK CITY, NY / ACCESS Newswire / June 20, 2025 / AI is revol ...

Key TakeawaysThe global Anxiety Disorder Treatment Market is projected to grow from USD 12.7 billion in 2024 to USD 18.1 ...

The dry AMD treatment market is experiencing unprecedented growth, driven by increasing disease awareness, rising prevalence of age-related eye cond ...

Gilead Sciences, Inc. GILD obtained FDA approval for its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, for the ...